Disposable Plastic Blood Bags Market Segmented By Single, Double, Triple and Quadruple Blood Bags in Blood Banks, Hospital and Healthcare Institutes and Home Healthcare
Industry: Healthcare
Published Date: December-2014
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 92
Report ID: PMRREP3173
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methodology
1.3. Assumptions
Chapter 2. Market Synopsis
Chapter 3. Porter’s Five Forces Analysis
3.1. Bargaining Power of Suppliers
3.2. Bargaining Power of Buyers
3.3. Threat of New Entrants
3.4. Threat of Substitutes
3.5. Intensity of Rivalry
Chapter 4. Industry Overview
4.1. Market Definition
4.2. Market Drivers
4.2.1. Increasing prevalence of chronic diseases
4.2.2. Rising aging population
4.2.3. Increasing initiatives undertaken by various government associations spreading awareness about importance of blood donations
4.2.4. Advanced features of disposable plastic blood bags
4.3. Impact Analysis of Market Drivers
4.4. Market Restraints
4.4.1. Risks associated with blood transfusion and lack of awareness
4.4.2. Poor blood collection and storage infrastructure in various parts of the world
4.4.3. Lack of primary healthcare infrastructure in developing countries
4.5. Impact Analysis of Market Restraints
4.6. Market Trends
4.6.1. Increasing number of mergers and acquisitions
4.6.2. Increasing use of RFID technology in blood bags
4.7. Market Opportunities
4.7.1. Usage of non-PVC materials in blood bag
Chapter 5. Global Market Size and Forecast
5.1. On the Basis of Geography
5.2. On the Basis of Type
5.3. On the Basis of End Users
Chapter 6. Market Size and Forecast by Type
6.1. Single Blood Bags
6.2. Double Blood Bags
6.3. Triple Blood Bags
6.4. Quadruple Blood Bags
Chapter 7. Market Size and Forecast by End Users
7.1. Hospital and Healthcare Institutes
7.2. Blood Banks
7.3. Home Healthcare
Chapter 8. Market Size and Forecast by Geography
8.1. North America
8.2. Europe
8.3. Asia
Chapter 9. Competitive Scenario
9.1. Competitive Benchmarking
9.2. Company Share Analysis
Chapter 10. Company Profiles
10.1. Haemonetics Corporation
10.1.1. Company overview
10.1.2. Products and services
10.1.3. Financial performance
10.1.4. Key developments
10.2. Grifols, S.A.
10.2.1. Company overview
10.2.2. Products and services
10.2.3. Financial performance
10.2.4. Key developments
10.3. JMS Co., Ltd.
10.3.1. Company overview
10.3.2. Products and services
10.3.3. Financial performance
10.3.4. Key developments
10.4. Kawasumi Laboratories, Inc.
10.4.1. Company overview
10.4.2. Products and services
10.4.3. Financial performance
10.4.4. Key developments
10.5. AdvaCare Pharma
10.5.1. Company overview
10.5.2. Products and services
10.5.3. Financial performance
10.5.4. Key developments
10.6. Fresenius SE & Co. KGaA
10.6.1. Company overview
10.6.2. Products and services
10.6.3. Financial performance
10.6.4. Key developments
10.7. Terumo Corporation
10.7.1. Company overview
10.7.2. Products and services
10.7.3. Financial performance
10.7.4. Key developments
10.8. MacoPharma, S.A.
10.8.1. Company overview
10.8.2. Products and services
10.8.3. Financial performance
10.8.4. Key developments
10.9. GenesisBPS
10.9.1. Company overview
10.9.2. Products and services
10.9.3. Financial performance
10.9.4. Key development
10.10. SURU International Pvt. Ltd.
10.10.1. Company overview
10.10.2. Products and services
10.10.3. Financial performance
10.10.4. Key developments
10.11. Shanghai Transfusion Technology Co., Ltd.
10.11.1. Company overview
10.11.2. Products and services
10.11.3. Financial performance
10.11.4. Key developments
10.12. Sichuan Nigale Biomedical Co., Ltd.
10.12.1. Company overview
10.12.2. Products and services
10.12.3. Financial performance
10.12.4. Key developments
10.13. Neomedic Limited
10.13.1. Company overview
10.13.2. Products and services
10.13.3. Financial performance
10.13.4. Key developments
10.14. Shandong Weigao Group Medical Polymer Co., Ltd.
10.14.1. Company overview
10.14.2. Products and services
10.14.3. Financial performance
10.14.4. Key developments
List of Table
TABLE 1: Market snapshot: Global market of disposable plastic blood bags (2014 and 2020) 11
TABLE 2: Drivers for disposable plastic blood bags market: Impact analysis 21
TABLE 3: Restraints for disposable plastic blood bags market: Impact analysis 24
TABLE 4: Some of the major mergers and acquisitions in disposable plastic blood bags market 25
TABLE 5: Global disposable plastic blood bags market size, by region, 2010 – 2013 (USD thousand) 29
TABLE 6: Global disposable plastic blood bags market size, by region, 2014 – 2020 (USD thousand) 29
TABLE 7: Global disposable plastic blood bags market size, by type, 2010 – 2013 (USD thousand) 31
TABLE 8: Global disposable plastic blood bags market size, by type, 2014 – 2020 (USD thousand) 31
TABLE 9: Global disposable plastic blood bags market size, by end users, 2010 – 2013 (USD thousand) 33
TABLE 10: Global disposable plastic blood bags market size, by end users, 2014 – 2020 (USD thousand) 33
TABLE 11: Global single blood bags market size, by region, 2010 – 2013 (USD thousand) 35
TABLE 12: Global single blood bags market size, by region, 2014 – 2020 (USD thousand) 35
TABLE 13: Global double blood bags market size, by region, 2010 – 2013 (USD thousand) 37
TABLE 14: Global double blood bags market size, by region, 2014 – 2020 (USD thousand) 37
TABLE 15: Global triple blood bags market size, by region, 2010 – 2013 (USD thousand) 38
TABLE 16: Global triple blood bags market size, by region, 2014 – 2020 (USD thousand) 39
TABLE 17: Global quadruple blood bags market size, by region, 2010 – 2013 (USD thousand) 41
TABLE 18: Global quadruple blood bags market size, by region, 2014 – 2020 (USD thousand) 41
TABLE 19: Global hospital and healthcare institutes market size, by region, 2010 – 2013 (USD thousand) 43
TABLE 20: Global hospital and healthcare institutes market size, by region, 2014 – 2020 (USD thousand) 43
TABLE 21: Global blood banks market size, by region, 2010 – 2013 (USD thousand) 44
TABLE 22: Global blood banks market size, by region, 2014 – 2020 (USD thousand) 45
TABLE 23: Global home healthcare market size, by region, 2010 – 2013 (USD thousand) 46
TABLE 24: Global home healthcare market size, by region, 2014 – 2020 (USD thousand) 47
TABLE 25: North American disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 49
TABLE 26: North American disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 50
TABLE 27: European disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 52
TABLE 28: European disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 53
TABLE 29: Asian disposable plastic blood bags market size, by country, 2010 – 2013 (USD thousand) 55
TABLE 30: Asian disposable plastic blood bags market size, by country, 2014 – 2020 (USD thousand) 56
TABLE 31: Products and services categories of Haemonetics Corporation 60
TABLE 32: Products and services categories of Grifols, S.A. 62
TABLE 33: Products and services categories of JMS 66
TABLE 34: Products and services categories of Kawasumi Laboratories, Inc. 68
TABLE 35: Products and service categories of AdvaCare Pharma 70
TABLE 36: Products and services categories of Fresenius SE & Co. KGaA 72
TABLE 37: Products and services categories of Terumo Corporation 75
TABLE 38: Products and service categories of MacoPharma, S.A. 77
TABLE 39: Products and service categories of GenesisBPS 79
TABLE 40: Products and service categories of SURU International Pvt. Ltd. 81
TABLE 41: Plasma and blood products and services categories of Sichuan Nigale Biomedical Co., Ltd. 85
TABLE 42: Plasma and blood products and services categories of Neomedic Limited 88
TABLE 43: Products and services categories of Weigao Group 89
List of Figure
FIG. 1: Disposable plastic blood bags market: Porter’s five force analysis 13
FIG. 2: Disposable plastic blood bags market, by type 16
FIG. 3: Aging population in major countries, 2000 – 2050 (% share in total population) 19
FIG. 4: Global disposable plastic blood bags market share, by region, by value, 2013 28
FIG. 5: Global disposable plastic blood bags market share, by type, by value, 2013 30
FIG. 6: Global disposable plastic blood bags market share, by end users, by value, 2013 32
FIG. 7: Global single blood bags market share, by region, by value, 2013 34
FIG. 8: Global double blood bags market share, by region, by value, 2013 36
FIG. 9: Global triple blood bags market share, by region, by value, 2013 38
FIG. 10: Global quadruple blood bags market share, by region, by value, 2013 40
FIG. 11: Global hospital and healthcare institutes market share, by region, by value, 2013 42
FIG. 12: Global blood banks market share, by region, by value, 2013 44
FIG. 13: Global home healthcare market share, by region, by value, 2013 46
FIG. 14: North American disposable plastic blood bags market share, by country, by value, 2013 49
FIG. 15: European disposable plastic blood bags market share, by country, by value, 2013 52
FIG. 16: Asian disposable plastic blood bags market share, by country, by value, 2013 55
FIG. 17: Competitive landscape of disposable plastic blood bag providers, 2013 57
FIG. 18: Global disposable plastic blood bags market, by company, 2013 (% share) 58
FIG. 19: Haemonetics Corporation’s net revenue and net income, 2012 – 2014 (USD million) 60
FIG. 20: Grifols’ net sales and profit after tax, 2011 – 2013 (USD million) 64
FIG. 21: JMS’ net sales and net income, 2012 – 2014 (USD million) 67
FIG. 22: Kawasumi Laboratories, Inc.’s net sales and net income, 2012 – 2014 (USD million) 69
FIG. 23: Fresenius SE & Co. KGaA’s sales and net income, 2011 – 2013 (USD billion) 73
FIG. 24: Terumo Corporation’s net sales and net income, 2012 – 2014 (USD million) 76
FIG. 25: Weigao Group’s revenue and profit, 2011 – 2013 (USD million) 90